Plain-English translation of NCT02691689 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are looking for genetic clues that might explain why some people born with certain heart defects (like atrial or ventricular septal defects) develop dangerously high blood pressure in their lungs, while others do not. By studying your genes, they hope to identify patterns that could help doctors predict who is at highest risk and catch this problem earlier, before it becomes serious.
Right now, doctors usually only discover this lung pressure problem after symptoms appear and it has already become advanced and harder to treat. If researchers can identify the genetic factors that make some people more vulnerable, genetic screening could become a powerful tool for early detection and prevention.
You likely qualify if…
You likely don't qualify if…
You would visit the hospital once to have a blood sample drawn and provide medical information about your heart condition and family history. The researchers will then analyze your genes to look for mutations linked to lung artery pressure problems. This is a diagnostic study, meaning there is no medication or treatment being given — the focus is on understanding your genetic makeup to improve future care.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Belgium